Aster DM Healthcare receives NCLT order for merger with Quality Care India Ltd
Aster DM Healthcare has received NCLT approval to convene shareholder and creditor meetings for its merger with Quality Care India Ltd. The meetings are scheduled between February 27, 2026, and March 13, 2026. The merger is expected to be completed by Q1 FY27, creating one of India's top three hospital chains with over 10,360 beds.
The merger of Aster DM Healthcare and Quality Care India Ltd is a large-scale corporate action that will significantly alter the company's structure, market position, and operational scale, impacting stakeholders, patients, and the broader healthcare industry.
The NCLT order to convene meetings for the merger approval is a significant positive step towards the completion of the amalgamation, which is expected to create a larger, more competitive healthcare entity.
Aster DM Healthcare Limited has received an order from the Hon’ble National Company Law Tribunal (NCLT), Hyderabad Bench, to convene meetings of its shareholders and unsecured creditors for the approval of its proposed amalgamation with Quality Care India Limited. The meetings are scheduled to be held between February 27, 2026, and March 13, 2026.
This development follows earlier approvals from the Competition Commission of India (CCI) and no objection letters from the stock exchanges. The company anticipates completing the merger process by the first quarter of FY27, contingent upon receiving all necessary regulatory approvals and fulfilling other conditions precedent.
The combined entity, to be named 'Aster DM Quality Care Limited', will be promoted by Aster Promoters and Blackstone. It aims to become one of India's top three hospital chains, with a combined bed strength of over 10,360 beds across the country as of September 30, 2025. Aster DM Healthcare currently operates 19 hospitals with 5,199 beds, while Quality Care India Ltd has 5,165+ beds. The merged entity plans to increase its bed capacity to over 14,715 beds in the coming years and will integrate leading brands such as Aster DM, CARE Hospitals, KIMSHEALTH, and Evercare.
Dr. Azad Moopen, Founder & Chairman of Aster DM Healthcare, expressed confidence in the merger's approval and speedy completion by Q1 FY27. He highlighted the strategic importance of the merger in leveraging complementary networks, clinical expertise, and operational strengths to build a resilient, future-ready healthcare organization focused on enhancing patient access and outcomes. The merged entity also plans to invest in advanced medical technologies and digital health platforms.
What to do with a filing like this
Aster DM Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under amalgamation. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Aster DM Healthcare Limited. Read the original for the full detail.